A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Two Different Formulations of Long-acting Cabotegravir in Healthy Adult Participants
Condition(s):HIV InfectionsLast Updated:February 15, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:February 15, 2024Recruiting
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:January 13, 2017Completed
Condition(s):Human Immunodeficiency VirusLast Updated:November 5, 2015Withdrawn
Condition(s):HIV InfectionsLast Updated:November 30, 2023Active, not recruiting
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:June 22, 2020Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:May 21, 2021Available
Condition(s):Pre-Exposure Prophylaxis (PrEP); Breast FeedingLast Updated:February 5, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:May 19, 2023Not yet recruiting
Condition(s):HIV InfectionsLast Updated:August 29, 2022Not yet recruiting
Condition(s):HIV InfectionsLast Updated:February 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.